Why polyplexing is the future of ultra-sensitive analysis

In the realm of bioanalytics, researchers often face the challenge of measuring multiple analytes simultaneously, especially when dealing with rare matrices or hard-to-access samples. Two approaches come into play here: multiplexing and polyplexing. On the one hand, multiplexing allows for the simultaneous detection of different target antigens in a single well. However, assay parameters often have to compromise and cannot be optimized for each analyte individually.

Polyplexing, on the other hand, offers a superior solution. By separating multiplex analysis into several small polyplex assays, polyplexing eliminates unwanted cross-reactivity of antibody pairs . This approach additionally enables the detection of different analytes under individually optimized assay conditions. With the combination of AnySource® dilution technology and the Imperacer® platform, even the smallest sample materials can be divided into multiple sub-aliquots, allowing for extremely sensitive and specific detection and quantification of a complete panel of targets from a single source.

Polyplexing ensures that you receive precise and reliable data without compromising on sample quantity or sensitivity. Trust Chimera to elevate your research to the next level and optimize your bioanalytical processes.